Trials / Sponsors / Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma Metastatic Colorectal Carcinoma, Neuropathy | Phase 1 / Phase 2 | 2023-01-09 |
| Completed | BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients Neuropathy;Peripheral, Chemotherapy-induced Peripheral Neuropathy | EARLY_Phase 1 | 2022-10-17 |
| Terminated | A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant | Phase 1 | 2021-05-24 |
| Terminated | Continued Treatment for Participants Enrolled in Studies of BXQ-350 Neoplasms | Phase 1 | 2020-06-08 |
| Terminated | A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors Neoplasms | Phase 1 | 2019-04-15 |
| Completed | Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors Neoplasms | Phase 1 | 2016-09-01 |